ABCDx

ABCDx is a private Swiss-Spanish diagnostics company focused on point-of-care neurodiagnostics for acute brain injury. The company develops blood-based biomarker tests and software-enabled decision-support tools for stroke and traumatic brain injury, with a particular emphasis on rapid triage in emergency and pre-hospital settings. Its lead product, LVOCheck, is designed to identify large vessel occlusion stroke from a finger-prick blood sample, while BRAINCheck and related digital tools integrate biomarker and clinical data to support care decisions. ABCDx also advances biomarker programs for traumatic brain injury, including pediatric mild TBI and outcome prediction. The company appears to operate as a biomarker-platform business rather than a therapeutics developer, combining proprietary biomarker IP, assay development, and AI-supported software.